Global Lacrimal Duct Stent Tube Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Therapy Type;

Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other Therapy Types.

By End-User;

Hospitals, Clinics and Home Healthcare.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn569815139 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Lacrimal Duct Stent Tube Market (USD Million), 2021 - 2031

In the year 2024, the Global Lacrimal Duct Stent Tube Market was valued at USD 83.27 million. The size of this market is expected to increase to USD 125.21 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.0%.

The Global Lacrimal Duct Stent Tube Market is witnessing significant growth driven by a rising prevalence of lacrimal duct obstructions and an increasing number of surgical procedures aimed at addressing such conditions. Lacrimal duct stent tubes are medical devices used to treat nasolacrimal duct obstructions by maintaining the patency of the tear ducts, facilitating tear drainage, and preventing tear pooling. These devices are essential for patients suffering from conditions such as congenital nasolacrimal duct obstruction (CNLDO), acquired nasolacrimal duct obstruction (ANDO), and other lacrimal drainage system disorders. The market's expansion is further fueled by technological advancements in stent design, materials, and insertion techniques, improving patient outcomes and reducing procedural complications.

Product segmentation in the lacrimal duct stent tube market includes silicone stents, polyurethane stents, and other materials. Silicone stents dominate the market due to their biocompatibility, flexibility, and ease of insertion. These stents are preferred for their long-term efficacy and low risk of complications such as stent migration or tissue irritation. Polyurethane stents are also gaining traction, offering advantages such as increased durability and resistance to biofilm formation. Other materials, including metals and biodegradable polymers, cater to specific clinical needs and preferences, contributing to the market's overall diversity and growth.

Geographically, the market is segmented into North America, Europe, Asia Pacific, Middle East, and Africa, and Latin America. North America holds the largest market share, driven by the high prevalence of lacrimal duct disorders, well-established healthcare infrastructure, and significant investments in ophthalmic research and development. Europe follows closely, with advancements in healthcare technology and increasing adoption of minimally invasive procedures boosting market growth. The Asia Pacific region is experiencing rapid growth, attributed to rising healthcare expenditure, improving accessibility to healthcare services, and a growing patient pool with lacrimal duct disorders. Emerging markets in the Middle East, Africa, and Latin America are also witnessing increasing demand for lacrimal duct stent tubes due to improving healthcare facilities and rising awareness about ophthalmic disorders.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Therapy Type
    2. Market Snapshot, By End-User
    3. Market Snapshot, By Region
  4. Global Lacrimal Duct Stent Tube Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Aging Population
        2. Advancements in Medical Technology
        3. Rising Awareness and Diagnosis
      2. Restraints
        1. Limited Reimbursement Policies
        2. Complications and Risks
        3. Stringent Regulatory Approval Processes
      3. Opportunities
        1. Emerging Markets
        2. Customization and Personalization
        3. Collaborations and Partnerships
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Lacrimal Duct Stent Tube Market, By Therapy Type, 2021 - 2031 (USD Million)
      1. Oral Iron Therapy
      2. Parenteral Iron Therapy
      3. Red Blood Cell Transfusion
      4. Other Therapy Types
    2. Global Lacrimal Duct Stent Tube Market, By End-User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
      3. Home Healthcare
    3. Global Lacrimal Duct Stent Tube Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Pharmacosmos AS
      2. Sanofi Aventis
      3. Allergan PLC
      4. Pieris Pharmaceuticals Inc.
      5. AMAG Pharmaceuticals Inc.
  7. Analyst Views
  8. Future Outlook of the Market